SAB Biotherapeutics Files Q1 2025 10-Q
Ticker: SABSW · Form: 10-Q · Filed: May 9, 2025 · CIK: 1833214
| Field | Detail |
|---|---|
| Company | Sab Biotherapeutics, Inc. (SABSW) |
| Form Type | 10-Q |
| Filed Date | May 9, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financials
TL;DR
SAB Bio's Q1 10-Q is in. Check financials for preferred stock & warrants.
AI Summary
SAB Biotherapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Big Cypress Acquisition Corp., reported on its financial status, including details on preferred stock and warrants. The filing also references its business address in Miami Beach, Florida.
Why It Matters
This filing provides insight into SAB Biotherapeutics' financial health and capital structure as of Q1 2025, which is crucial for investors assessing the company's operational capacity and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, SAB Biotherapeutics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for this 10-Q filing.)
- 20250509 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- SAB Biotherapeutics, Inc. (company) — Filer of the 10-Q
- Big Cypress Acquisition Corp. (company) — Former name of SAB Biotherapeutics, Inc.
- Miami Beach, Florida (location) — Business address of SAB Biotherapeutics, Inc.
- March 31, 2025 (date) — End of the reporting period for the 10-Q
FAQ
What was the previous name of SAB Biotherapeutics, Inc.?
The previous name was Big Cypress Acquisition Corp., with a name change date of 20201120.
What is the primary business of SAB Biotherapeutics, Inc.?
The company is in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) industry, SIC code 2836.
Where is SAB Biotherapeutics, Inc. located?
The company's business and mailing address is 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL 33140.
What is the SEC file number for SAB Biotherapeutics, Inc.?
The SEC file number is 001-39871.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 9, 2025 regarding SAB Biotherapeutics, Inc. (SABSW).